About this trial
The aim of this study is to evaluate the effects of a solution-focused approach-based individual intervention on psychosocial adjustment and treatment adherence in individuals diagnosed with schizophrenia.
The study will be conducted as a randomized controlled trial including 60 clinically stable individuals diagnosed with schizophrenia according to DSM-5 criteria and registered at a Community Mental Health Center affiliated with a university hospital. Participants will be randomly assigned to an experimental group (n=30) and a control group (n=30).
The experimental group will receive one individual solution-focused therapy session per week for six weeks. The control group will receive usual care only. Data will be collected using a Personal Information Form, the Psychosocial Adjustment Scale (PSSAS), and the Medication Adherence Scale (MARS).
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Having been diagnosed with schizophrenia according to DSM-5 diagnostic criteria,
Disqualifiers
those who do not meet the inclusion criteria
Trial design
Parallel
Treatments tested in this trial
solution-oriented approach program
BehavioralThe solution-focused nursing intervention applied to the experimental group in the study was planned as individual sessions, consisting of one session per week, lasting a total of six weeks. The interventions were based on the principles of solution-focused brief therapy, focusing on the individual's strengths, past coping experiences, and current resources. The interviews aimed to identify exceptions, build positive future expectations, set small but achievable goals, strengthen hope, and increase the individual's ability to utilize their internal resources. Each session used structured open-ended questions, scaling techniques, and future-oriented solution scenarios to support the individual's psychosocial adjustment and motivation for treatment.
Treatment groups
Trial outcomes
Primary outcomes
pretest (6-week solution-focused approach before the intervention)
1\. Psychosocial Adjustment (PSSAS) Description: Measured with the Psychosocial Adjustment Scale (PSSAS), which assesses social relationships, daily life management, and coping with stress. Scores range from 0 to 180; higher scores indicate better psychosocial adjustment. Time Frame: Baseline (within 1 week before intervention) Unit of Measure: Total score (0-180)
pretest (6-week solution-focused approach before the intervention)
2\. Medication Adherence (MARS) Description: Measured with the Medication Adherence Scale (MARS), which assesses adherence to prescribed pharmacological treatment. Scores range from 0 to 10; higher scores indicate better medication adherence. Time Frame: Baseline (within 1 week before intervention) Unit of Measure: Total score (0-10)
Secondary outcomes
posttest (After the 6-week solution-focused approach intervention)
1\. Psychosocial Adjustment Post-Intervention (PSSAS) Description: Psychosocial Adjustment Scale (PSSAS). Scores range from 0 to 180; higher scores indicate better psychosocial adjustment. Time Frame: 6 weeks after baseline (post-intervention) Unit of Measure: Total score (0-180)
posttest (After the 6-week solution-focused approach intervention)
2\. Medication Adherence Post-Intervention (MARS) Description: Medication Adherence Scale (MARS). Scores range from 0 to 10; higher scores indicate better medication adherence. Time Frame: Post-intervention (6 weeks after completion of the intervention) Unit of Measure: Total score (0-10)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.